Pfizer Inc. Stock
Pfizer Inc. Stock
The price for the Pfizer Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.045 (-0.120%).
With 22 Buy predictions and 3 Sell predictions Pfizer Inc. is one of the favorites of our community.
On the other hand, the target price of €37.00 is below the current price of €37.48 for Pfizer Inc., so the potential is actually -1.281%.
Our community identified positive and negative aspects for Pfizer Inc. stock for the coming years. 9 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pfizer Inc. stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Pfizer Inc. in the next few years
Pros
10
Could be worthwhile Investment >10% per year
7
Market Leader or Top 3
7
Known brand
Cons
3
Sustainability is little important
Performance of Pfizer Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Pfizer Inc. | -0.120% | 0.307% | -6.874% | 27.175% | 24.050% | 6.407% | 32.230% |
| Merck & Co. Inc. | 0.220% | 2.865% | -3.531% | -12.003% | -5.377% | 4.717% | 14.340% |
| Eli Lilly Corp. | -2.000% | 0.816% | -11.044% | 53.010% | 45.426% | 118.798% | 178.364% |
| AbbVie Inc. | 1.480% | -0.512% | -10.779% | 23.220% | 6.790% | 13.094% | 57.797% |
Comments
Other discussions about Pfizer Inc. Stock
Trading Pfizer Inc.
Trading Pfizer Inc.
News
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults
Pfizer Inc. (NYSE: PFE) today announced the start of the Phase 2/3 EPIC-PEP (Evaluation of Protease Inhibition for COVID-19 in Post-Exposure Prophylaxis) study to evaluate the investigational novel
Pfizer Invites Public to View and Listen to Webcast of Pfizer November 2 Conference Call with Analysts
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 2, 2021. The
Pfizer Declares Fourth-Quarter 2021 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a 39-cent fourth-quarter 2021 dividend on the company’s common stock, payable December 6, 2021, to holders of the Common